MSTQX Performance — Morningstar U.S. Equity Fund, Institutional Class
Data updated: 2026-09-28
MSTQX returned +7.87% year to date and +13.74% over one year to Jul 2026. Annualised returns are +14.78% over 3 years and +9.91% over 5 years. The fund trailed its US Large Blend category average: $100 invested three years ago grew to $151, against $153 for the category, and to $114 over one year, against $116. Volatility over the past three years was 12.27% a year. In the 12 months to Jul 2026 the fund took in a net $165.5M, and assets reached $1.91B.
MSTQX Growth of $100
What $100 invested in Morningstar U.S. Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | MSTQX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $114 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $151 | $153 |
| 5 years (Aug 2021 – Jul 2026) | $160 | $159 |
| Since data start (Feb 2020 – Jul 2026) | $215 | $213 |
MSTQX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.87% |
| 1 year | +13.74% |
| 3 years (annualised) | +14.78% |
| 5 years (annualised) | +9.91% |
MSTQX Annual Returns
Calendar-year total returns of Morningstar U.S. Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +7.87% |
| 2025 | +12.07% |
| 2024 | +18.86% |
| 2023 | +25.27% |
| 2022 | −16.22% |
| 2021 | +26.35% |
| 2020 (Feb–Dec) | +12.95% |
MSTQX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.2% | −0.2% | −5.5% | +7.4% | +2.4% | −0.5% | +2.3% | — | — | — | — | — |
| 2025 | +3.3% | −1.4% | −5.0% | −1.2% | +5.5% | +4.1% | +1.3% | +2.1% | +2.1% | +0.6% | +0.1% | +0.5% |
| 2024 | +1.1% | +5.0% | +3.3% | −4.7% | +4.2% | +1.5% | +3.0% | +2.6% | +1.2% | −1.0% | +6.0% | −4.2% |
| 2023 | +7.8% | −2.4% | +1.6% | +1.3% | −0.3% | +6.8% | +3.2% | −2.0% | −4.7% | −2.2% | +8.9% | +5.7% |
| 2022 | −4.4% | −1.9% | +1.9% | −7.6% | +0.6% | −8.0% | +8.3% | −3.7% | −9.3% | +8.2% | +5.5% | −5.0% |
| 2021 | −0.2% | +4.5% | +5.0% | +5.1% | +2.2% | +0.6% | +0.4% | +2.3% | −3.0% | +5.6% | −2.6% | +4.2% |
| 2020 | — | −8.5% | −18.3% | +14.9% | +6.0% | +1.0% | +4.0% | +5.1% | −4.0% | −0.9% | +13.8% | +3.8% |
MSTQX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 12.27%
- 3-year Sharpe ratio: 0.84 (vs 4.5% risk-free rate)
- Best month: +8.93% (Nov 2023)
- Worst month: −5.50% (Mar 2026)
MSTQX Fund Flows
Monthly money in and out of Morningstar U.S. Equity Fund, from SEC Form N-PORT.
- 12-month net flow: $165.5M
- 12-month gross sales (incl. reinvestments): $609.6M
- Sales ÷ redemptions: 1.37×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $19.1M | $35.6M | −$16.5M |
| Jun 2026 | $23.7M | $35.9M | −$12.2M |
| May 2026 | $23.4M | $31.7M | −$8.3M |
| Apr 2026 | $55.0M | $36.8M | $18.2M |
| Mar 2026 | $23.4M | $29.1M | −$5.6M |
| Feb 2026 | $19.4M | $22.9M | −$3.5M |
| Jan 2026 | $31.2M | $58.6M | −$27.5M |
| Dec 2025 | $341.4M | $69.6M | $271.8M |
| Nov 2025 | $15.5M | $29.2M | −$13.7M |
| Oct 2025 | $20.3M | $29.8M | −$9.5M |
| Sep 2025 | $18.9M | $36.9M | −$18.0M |
| Aug 2025 | $18.3M | $27.9M | −$9.7M |
MSTQX Assets Under Management
Net assets of Morningstar U.S. Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.91B |
| 2026-04-30 | $1.87B |
| 2026-01-30 | $1.84B |
| 2025-10-31 | $1.86B |
| 2025-07-31 | $1.81B |
| 2025-04-30 | $1.60B |
| 2025-01-31 | $1.70B |
| 2024-10-31 | $1.70B |
| 2024-07-31 | $1.69B |
| 2024-04-30 | $1.60B |
| 2024-01-31 | $1.60B |
| 2023-10-31 | $1.41B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.